These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9540343)

  • 1. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
    Tsuyuguchi N
    Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography elucidates transport system and tumor proliferation in meningiomas.
    Murakami M; Imahori Y; Kimura S; Tatsuzawa K; Ohwada K; Inoue Y; Sasajima H; Mineura K
    Oncol Rep; 2005 Oct; 14(4):853-9. PubMed ID: 16142342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
    Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
    No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
    Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of vestibular schwannomas using positron emission tomography and monoclonal antibody Ki-67.
    Chen JM; Houle S; Ang LC; Commins D; Allan K; Nedzelski J; Rowed D
    Am J Otol; 1998 Nov; 19(6):840-5. PubMed ID: 9831165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Stanus E; Brotchi J; Hildebrand J
    Cancer; 1996 Sep; 78(5):1098-106. PubMed ID: 8780549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of
    Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
    Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
    Abry E; Thomassen IØ; Salvesen ØO; Torp SH
    Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Longitudinal analysis of glucose metabolism in recurrent meningioma].
    Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1994 Nov; 46(11):1088-93. PubMed ID: 7873283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
    Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
    Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy.
    Yamada M; Niwa Y; Matsuura T; Miyahara R; Ohashi A; Maeda O; Ando T; Ohmiya N; Itoh A; Hirooka Y; Goto H
    Scand J Gastroenterol; 2007 May; 42(5):633-41. PubMed ID: 17454885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
    Mu DB; Wang SP; Yang WF; Fu Z; Chen XX; Sun XR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):30-3. PubMed ID: 17575690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
    Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
    Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
    Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
    J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and methionine uptake and proliferative activity in meningiomas.
    Iuchi T; Iwadate Y; Namba H; Osato K; Saeki N; Yamaura A; Uchida Y
    Neurol Res; 1999 Oct; 21(7):640-4. PubMed ID: 10555183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
    Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
    Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis].
    Cremerius U; Striepecke E; Henn W; Weis J; Mull M; Lippitz B; Gilsbach J; Schröder JM; Zang KD; Böcking A
    Nuklearmedizin; 1994 Aug; 33(4):144-9. PubMed ID: 7971289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.